Gonadotropins at menopause: The influence of obesity, insulin resistance, and estrogens

Steroids

Volumn 66, Issue 7, 2001, Pages 559-567

  Malacara, Juan M ^a   Fajardo, Martha E ^a   Nava, Laura E ^a  

^a UNIVERSITY OF GUANAJUATO   (Mexico)

Author keywords

Gonadotropins; Insulin resistance; Menopause; Obesity; Steroids

Indexed keywords

ANDROSTENEDIONE; CLOMIFENE CITRATE; FOLLITROPIN; GONADOTROPIN; METFORMIN; PRASTERONE SULFATE; RALOXIFENE; TROGLITAZONE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MENOPAUSE; OBESITY;

CHROMANS; CLOMIPHENE; ESTROGENS; FEEDBACK, BIOCHEMICAL; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPINS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MENOPAUSE; METFORMIN; MIDDLE AGED; OBESITY; PREGNANCY; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0035400822     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(00)00223-3     Document Type: Article

References (25)

1. Phyto-oestrogens and breast cancer
2. Estrogen synthesis in castrated women; the action of human chorionic gonadotropin and corticotropin
3. The effect of obesity in the conversion of plasma androstenedione to estrone in ovulatory and anovulatory young women
4. Physiological changes in dehydroepiandrosterone are not reflected in serum levels of active androgens and estrogens but of their metabolites; intracrinology
5. Gonadotropins and prolactin serum levels during the perimenopausal period; correlation with diverse factors
6. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism
7. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17α and serum androgens
8. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome
9. Improvement of endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome
10. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
11. Effects of metformin on insulin secretion, insulin action and ovarian steroidogenesis in women with polycystic ovary syndrome
12. Effects of metformin on spontaneous and clomiphene-induced ovulation
13. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis and fibrinolysis in women with polycystic ovary syndrome
14. The insulin sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome
15. High frequency FSH and LH pulses in obese menopausal women
16. Homeostasis model assessment; insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
17. The endocrinology of the menopausal transition; a cross-sectional study of a population-based study
18. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and dimeric inhibin during the menopausal transition in a population-based cohort
19. Polycystic ovary syndrome as a form on functional ovarian hyperandrogenism
20. Insulin infusion amplifies 17α-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women; apparent relative impairment of 17,20-lyase activity
21. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus
22. Peroxisome proliferator-activated receptors; nuclear control of metabolism